Table I.
Sample no. | Carcinogen | Histology | Immuno-reactivity Score | DNA Sequencing Ctnnb1 exon 3 | |
---|---|---|---|---|---|
ca | /na | ||||
normal rat kidney | |||||
NK | none | normal rat kidney | + | − | wtd |
primary nephroblastomas | |||||
N1 | ENUb | Triphasic | ++ | + | wt |
N2 | ENU | Triphasic, predominant blastemal | ++ | + | wt |
N3 | ENU | Triphasic, predominant blastemal | + | + | wt |
N4 | ENU | Triphasic, predominant blastemal | + | − | wt |
N5 | ENU | Triphasic, predominant blastemal/stromal | ++ | − | wt |
N6 | ENU | Triphasic, weak differentiated | + | + | wt |
N7 | ENU | Triphasic, predominant blastemal | + | + | wt |
N8e | ENU | Triphasic | ++ | − | wt |
N9e | ENU | Triphasic | ++ | − | wt |
N10e | ENU | Triphasic | + | − | wt |
N11e | ENU | Triphasic, mainly blastemal | ++ | + | wt |
N12e | ENU | Triphasic | + | + | wt |
N13e | ENU | Triphasic | + | + | wt |
N14e | ENU | Triphasic | + | − | wt |
N15e | ENU | Triphasic | − | − | wt |
N16 | DMN-OMec | Triphasic, predominant blastemal | + | + | wt |
N17 | DMN-OMe | Triphasic, predominant stromal | ++ | + | wt |
N18 | DMN-OMe | Triphasic, predominant stomal, anaplastic | ++ | + | wt |
transplanted nephroblastomas | |||||
HT1e | ENU | Triphasic, predominant blastemal with focal epithelium | ++ | + | wt |
HT2e | ENU | Triphasic, predominant bastemal | ++ | + | wt |
HT3e | ENU | Triphasic, predominant blastemal | + | + | wt |
HT4e | ENU | Triphasic, predominant blastemal | + | − | wt |
HT5e | ENU | Triphasic, predominant mesenchymal | − | + | wt |
HT6e | ENU | Triphasic, predominant blastemal/stromal | − | + | wt |
HT7e | ENU | Triphasic | + | − | wt |
cell lines | |||||
ENU-T1 | ENU | adherent cells | wt | ||
CC531 | adherent cells | Codon 41, ACC→ATC Thr→Ile |
c/n, cytoplasmatic/nuclear staining
ENU, transplacental ENU treated animals
DMN, neonatal DMN-Ome treated animals
wt, wild type
DNA extracted by microdissection